Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Pharmaceuticals
Medical Devices
About Investor
Clay Thorp is a General Partner at Hatteras Venture Partners. He focuses on early-stage investments in Medical Devices, Pharmaceuticals, BioTech, and Diagnostics. His investments typically range from Seed to Series A stages. Clay is based in the Raleigh-Durham/Southeast US area. His background includes extensive experience in healthcare and biotech sectors.
Previous investments
Myeloid Therapeutics
73M |2023
Ten63 Therapeutics
16M |2023
Rodin Therapeutics
27M |2017
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free